R, D., F, N., C, N., R, P., Y, D., M, B., & W, O. (2010). Intravenous immunoglobulins as a treatment for Alzheimer's disease: Rationale and current evidence. Drugs, 70(5), 513. https://doi.org/10.2165/11533070-000000000-00000
Chicago Style (17th ed.) CitationR, Dodel, Neff F, Noelker C, Pul R, Du Y, Bacher M, and Oertel W. "Intravenous Immunoglobulins as a Treatment for Alzheimer's Disease: Rationale and Current Evidence." Drugs 70, no. 5 (2010): 513. https://doi.org/10.2165/11533070-000000000-00000.
MLA (9th ed.) CitationR, Dodel, et al. "Intravenous Immunoglobulins as a Treatment for Alzheimer's Disease: Rationale and Current Evidence." Drugs, vol. 70, no. 5, 2010, p. 513, https://doi.org/10.2165/11533070-000000000-00000.
Warning: These citations may not always be 100% accurate.